Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

NCT03879512 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Childhood Glioblastoma

Interventions

DRUG: depletion of regulatory T cells
PROCEDURE: reoperation
BIOLOGICAL: cancer vaccine
BIOLOGICAL: checkpoint blockade

Sponsor

Wuerzburg University Hospital